findmyKOL
Clinical trialNCT04335682CompletedPhase 2Interventional

Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide

SponsorAlliance Foundation Trials, LLC.Enrollment111Castrate Resistant Prostate CancerHormone Sensitive Prostate CancerMetastatic Prostate CancerNon-metastatic Prostate CancerProstate CancerProstate Cancer Metastatic
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California - San Francisco at Mount Zion

    San Francisco, California, United States

  • Northwestern University Feinberg School of Medicine

    Chicago, Illinois, United States

  • University of Chicago

    Chicago, Illinois, United States

  • University of Kansas Cancer Center

    Fairway, Kansas, United States

  • Dana Farber Cancer Institute

    Boston, Massachusetts, United States

  • University of Minnesota

    Minneapolis, Minnesota, United States

  • University of Oklahoma

    Oklahoma City, Oklahoma, United States

  • Froedtert and the Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
17 Aug 2021
Primary completion
1 Sept 2025
Completion
1 May 2026
Last update posted
18 Jun 2026
Registered enrollment
111
Registry id
NCT04335682

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.